COVID-19 RESPONSE

Click here to read about our efforts to help address the crisis.

Listen to our March 2nd presentation at the Cowen 40th Annual Health Care Conference by clicking here.

OUR PROGRAMS

liver icon
Peptide-Based Therapeutics for Liver Diseases

READ MORE >

Peptide-Conjugated Immunostimulants for Cancer - Icon
Peptide-Conjugated Immunostimulants for Cancer

READ MORE >

Intranasal vaccines for Anthrax and Influenza - icon
Intranasal vaccines for Anthrax and Influenza

READ MORE >

OUR PIPELINE

Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B (HepTcellTM), and conjugated immunostimulants for the treatment of cancer (ALT-702). In addition, we are developing intranasal vaccine programs for anthrax and influenza.

LIVER THERAPIES

liver therapies iconALT-801
liver therapies iconHepTcell™

CANCER

cancer iconALT-702

INTRANASAL VACCINES

intranasal vaccines iconNasoVAX™
intranasal vaccines iconNasoShield™
VIEW PIPELINE